Medicine
Tiglutik 50 mg/10 mL oral liquid
Tiglutik 50 mg/10 mL oral liquid is a prescription medicine containing Riluzole for oral use, marketed by Edw Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20-25°C (68-77°F), excursions permitted to 15-30°C…
Key facts
- Active ingredient (INN)
- Riluzole
- Brand
- Tiglutik
- Strength
- 50 mg/10 mL
- Dosage form
- Oral liquid
- Route
- Oral
- Packs
- 2 bottles
- Marketing authorisation holder
- Edw Pharma
- Manufacturer
- Edw Pharma
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20-25°C (68-77°F), excursions permitted to 15-30°C (59-86°F), and protect from bright light. Store upright.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07XX02 Riluzole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 September 2018
- Identifiers
- RxCUI 2058147, 2059266DailyMed set ID 75d68f19-4208-109e-e053-2991aa0ac857NDC 70726-0303Application NDA209080
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 bottle, plastic in 1 carton / 300 mL in 1 bottle, plastic | 70726-0303-1 | Edw Pharma | 21 September 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Riluzole
Clinical summary
Riluzole is a benzothiazole indicated for the treatment of amyotrophic lateral sclerosis (ALS). It is available as tablets, oral liquid and oral suspension. MedsAcross supplies Riluzole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RiluzoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TIGLUTIK prescribing information (Edw Pharma) · U.S. National Library of Medicine, DailyMed
- Rilutek: European public assessment report (EPAR) · European Medicines Agency
- Riluzole Zentiva: European public assessment report (EPAR) · European Medicines Agency
Need Tiglutik 50 mg/10 mL oral liquid for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.